Nema internetske veze — prikazuje se spremljena verzija stranice.

Silence Therapeut…

USUSD
← Na Filtar Dionica

Silence Therapeutics PLC (US:SLNCF) — Biotechnology: Pharmaceutical Preparations. Broj burzi na kojima se trguje dionicama tvrtke: 1. Na ovoj stranici — cijena i grafikon, dividende, najveći dioničari i povijest broja dionica.

O Tvrtki

Web-Stranica
silence-therapeutics.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sjedište
LONDON, United Kingdom
Glavni Direktor
Iain Gladstone Ross
Zaposlenici
88
Dionice u Optjecaju
141.74 mil. na dan 2026-07-31
Slobodno Prenosive Dionice
37.84 mil.
Tržišna Kapitalizacija
665.67 mil. USD
Insajderi
7.97%
Institucionalni Ulagači
39.68%
Djelatnost (SIC)
Pharmaceutical Preparations
FCF
−42.3 mil. USD
Dug
?
Zarada i FCF — za 12 mjeseci do 30.06.2026 (najnovije izvješće tvrtke).
NAV
0.27 USD · P/NAV 14.2
Datum Bilance30.06.2026
Imovina106 mil. USD
− Obveze67.9 mil. USD
= NAV (Kapital Dioničara Tvrtke)38.5 mil. USD
− Goodwill10.3 mil. USD
= Materijalna NAV28.1 mil. USD
Dionice141 739 180
NAV po Dionici0.27 USD
Opipljivi NAV po Dionici0.20 USD
Cijena Dionice (SLNCF)3.8500 USD
P/NAV14.18
Povijest NAV-a
Datum BilanceNAVNAV po Dionici
30.06.202638.5 mil. USD0.27 USD
31.03.202649.4 mil. USD0.35 USD
31.12.202562.3 mil. USD0.44 USD
30.09.202574.1 mil. USD0.52 USD
30.06.202594.2 mil. USD0.66 USD
31.03.2025113 mil. USD0.80 USD
31.12.2024134 mil. USD0.95 USD
30.09.2024127 mil. USD0.89 USD
Opis

Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, United Kingdom.

oglas

Burze i Oznake

BurzaOznakaValutaCijenaVrsta
US USA StocksSLNCFUSD3.85 -3.75%obične dionice

Cijena za 3 Mjeseca

US:SLNCF · USD
dan rasta dan padaPrijeđite mišem / dodirnite dan — cijene otvaranja, zatvaranja, najviša i najniža

Vijesti Ovog Tjedna

Priopćenja za medije s web stranice za investitore tvrtke, ažurirana svakodnevno. Poveznice vode na web stranicu tvrtke. Naslovi su na izvornom jeziku, kao na web stranici tvrtke.

Najveći Imatelji

ImateljUdioDioniceDatum Izvješća
Siren, L.L.C.5.5%3.31 mil.2026-06-30
TCG Crossover Management…5.04%3.03 mil.2026-06-30
Redmile Group, LLC3.6%2.16 mil.2026-06-30
Nantahala Capital Manage…2.24%1.35 mil.2026-06-30
Citadel Advisors Llc2.21%1.33 mil.2026-06-30
Nextech Invest, Ltd.1.58%952 4002026-06-30
Millennium Management Ll…1.51%909 2792026-06-30
Ikarian Capital, LLC1.38%830 7842026-06-30
Tetragon Partners GP Ltd…1.27%764 2562026-06-30
Soleus Capital Managemen…1.05%630 0002026-06-30
Fidelity Advisor Series…0.8%482 0882026-07-31
iShares Trust-iShares Bi…0.39%234 0092026-08-31
ALGER FUNDS-Alger Small…0.18%105 6792026-07-31
Fidelity Select Portfoli…0.17%103 9122026-07-31
ALGER INSTITUTIONAL FUND…0.07%41 2922026-07-31
Fidelity Concord Street…0.05%29 5382026-07-31
SPDR INDEX SHARES Fd.S-S…0.02%9 5322026-06-30
Trust for Professional M…0.01%8 6952026-05-31
Steward Funds Inc-Stewar…0.01%5 8002026-07-31
Invesco Exchange-Traded…0%2 9182026-08-31